AB SCIEX Expands Support in the Middle East
News Oct 29, 2013
This represents the company's continued investments in the Middle East to serve the scientific community in the region.
"The new AB SCIEX facility in Dubai builds on our forward momentum we have in the Middle East," said Khalid Ghaffar, AB SCIEX Manager for the Middle East and Africa. "AB SCIEX is now in a better position than ever to directly support the growing base of Middle Eastern scientists who are using mass spectrometry to analyse biological samples, food, soil or whatever substance in question and get faster, more accurate answers to their questions than other analytical technologies."
AB SCIEX is well-established as a leading provider of mass spectrometry solutions across the Middle East. Mass spectrometry is advanced scientific technology used in laboratories to detect and quantify compounds, contaminants and proteins across a wide variety of applications, including food safety, drug discovery, environmental analysis and biomedical research.
Service and support are important to mass spectrometry customers in the Middle East. With its expansion of service capabilities, state-of-the-art instrumentation and a stronger presence in the region, AB SCIEX is committed to providing high levels of application and technical support, particularly as the company expands its direct contact with customers.
"We are applying our global leadership, scientific expertise and resources at a local level in the Middle East to help advance science in multiple countries," said Rainer Blair, President of AB SCIEX. "The Middle East is an important geography for AB SCIEX and, as a trusted partner, we will continue to cultivate and grow our relationships with customers across the region."
The technical support centre provides pre- and post-sales support, including training and application support. The company also offers a stream of courses for continued education about analytical science in the Middle East.
Synaptic Proteins May Be Starting Point for Dementia TreatmentNews
A new study has identified key proteins, located at the brain's synaptic connections, which may be viable targets for dementia treatment.READ MORE